(Q53568114)

English

MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).

scientific article published in March 2007

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

title

MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L). (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

1 reference

Wenhua Li

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

Xiaoping Zhang

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

Aria F Olumi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

language of work or name

English

0 references

publication date

1 March 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

published in

Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

volume

67

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

page(s)

2247-2255

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

Identifiers

DOI

10.1158/0008-5472.CAN-06-3793

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

PubMed publication ID

17332355

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17332355

retrieved

15 May 2018

reference URL

http://europepmc.org/abstract/MED/17332355

(Q53568114)

MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)